Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

NCT00920907 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb

Collaborators